Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

2(50.0%)

4Total

N/A(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03877939Completed

Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy

Role: collaborator

NCT04092829Not ApplicableTerminated

Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer

Role: collaborator

NCT03493529Completed

Microbiome and Endometrial Receptivity in Obese Infertile Women

Role: collaborator

NCT01955356Not ApplicableCompleted

Embryo Implantation After Induced Endometrial Injury

Role: collaborator

NCT02567552Phase 4Completed

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

Role: lead

NCT04200118Unknown

Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment

Role: lead

NCT03860064Completed

Aneuploidy Rates of in Vitro Matured Oocytes

Role: lead

NCT02254928Phase 4Terminated

Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders

Role: collaborator

All 8 trials loaded